News

June 5, 2020
June 5, 2020 — (Cincinnati, OH) A University of Cincinnati physician-researcher says unlocking the key to how platelets function before, after and during transcatheter aortic valve replacement (TAVR) may provide insight as to why some patients undergoing the heart procedure have better outcomes than others.
June 5, 2020
DUBLIN, June 05, 2020 — Medtronic plc has received CE (Conformité Européenne) Mark for a one-month dual antiplatelet therapy (DAPT) indication for high bleeding risk (HBR) patients implanted with the Resolute Onyx™ Drug-Eluting Stent (DES). For HBR patients, whose bleeding risk may be increased by taking longer DAPT regimens (a combination of aspirin and an
June 4, 2020
Whether these rashes are in fact ischemic remains to be determined, due to the paucity of data from biopsy and other invasive assessments.
June 4, 2020
PARK CITY, Utah, June 4, 2020 — Transit Scientific announced the FDA cleared the XO Score Percutaneous Transluminal Angioplasty (PTA) Scoring Sheath platform for use in iliac, ilio-femoral, popliteal, infra-popliteal, and renal arterial plus synthetic and/or native arteriovenous
June 4, 2020
Heart attack patients worldwide avoid hospitals or present too late to benefit from life-saving treatment  
June 3, 2020
FRANKLIN LAKES, N.J. (June 1, 2020) – BD (Becton, Dickinson and Company) announced that it has completed the acquisition of Straub Medical AG, a privately-held company that develops and sells medical atherectomy and thrombectomy devices that treat peripheral arterial disease (PAD) and venous disease.
June 2, 2020
First-of-its-kind study evaluates ultra-short DAPT in PCI patients at high bleeding risk compared to drug-eluting stents